Melexis Q4 and FY 2025 results
Globenewswire· 2026-02-04 06:00
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - February 4th, 2026, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: https://www.melexis.com/en/news/2026/financial/melexis-q4-2025-results Attachment ...
Oil at $60 Forces Europe’s Energy Giants to Rethink Buybacks
Investing· 2026-02-04 06:00
Market Analysis by covering: Chevron Corp, Exxon Mobil Corp, Crude Oil WTI Futures. Read 's Market Analysis on Investing.com ...
NORBIT - Invitation to presentation of NORBIT's fourth quarter results, 11 February 2026
Globenewswire· 2026-02-04 06:00
Core Insights - NORBIT will announce its fourth quarter results for 2025 on February 11, 2026, with the interim report and presentation materials available from 07:00 am CET [1] - The results will be presented by CEO Per Jørgen Weisethaunet and CFO Per Kristian Reppe at 09:00 am CET [2] - NORBIT is a global provider of tailored technology, structured into three business segments: Oceans, Connectivity, and Product Innovation & Realization [2] Company Overview - NORBIT focuses on solving challenges and promoting sustainability through innovative solutions, aligning with its mission to "Explore More" [2] - The Oceans segment delivers technology solutions to global maritime markets, while the Connectivity segment provides wireless solutions for identification, monitoring, and tracking [2] - The Product Innovation & Realization segment offers R&D services, proprietary products, and contract manufacturing to key customers [2] - The company is headquartered in Trondheim, has around 650 employees, and operates manufacturing facilities in Europe and North America [2]
Borregaard ASA: EBITDA1 of NOK 405 million in the 4th quarter 2025
Globenewswire· 2026-02-04 06:00
Borregaard’s operating revenues increased to NOK 1,833 million (NOK 1,744 million)2 in the 4th quarter of 2025. EBITDA1 was NOK 405 million (NOK 398 million). The result in BioMaterials increased, while BioSolutions and Fine Chemicals had lower results compared with the 4th quarter of 2024. In BioSolutions, high deliveries of biovanillin and sustained growth in sales to agriculture were more than offset by increased costs. For BioMaterials, higher sales prices and lower wood and energy costs, more than comp ...
SCOR January 2026 P&C Reinsurance Renewals: Selective growth in a competitive pricing environment
Globenewswire· 2026-02-04 05:59
Core Insights - The P&C reinsurance market remains competitive, with SCOR achieving a targeted growth of 4.7% in traditional reinsurance and a significant 80.5% growth in Alternative Solutions during the January 2026 renewals [2][4]. Market Overview - Demand for reinsurance coverage is high, but competition has intensified due to strong profits and increased capital supply, leading to price reductions in most lines, particularly non-proportional placements [3][4]. - The P&C reinsurance book renewed on January 1, 2026, totaled EUR 4,493 million, reflecting a 4.7% increase compared to January 2024, with P&C Lines growing by 7.4% and Specialty Lines by 0.3% [3][4]. Company Performance - SCOR's net underwriting ratio is expected to increase by 2.0 percentage points, supported by retrocession buying [2][4]. - The growth in P&C Lines is attributed to a flight-to-quality trend, particularly in APAC and North America, and strong relationships with core clients [4]. - The company maintains disciplined underwriting practices, which contribute to active portfolio steering and margin protection in Specialty Lines [4]. Future Outlook - SCOR is prepared for continued competition in the reinsurance market and will pursue its Forward 2026 diversified growth strategy in a disciplined manner [5].
Amundi launches a 500 million euros share buyback programme
Globenewswire· 2026-02-04 05:59
Amundi launches a 500 million euros share buyback programme As announced during the publication of its 2025 annual results, Amundi announces today the launch of a 500 million euros share buyback programme. Amundi has mandated an independent investment services provider to carry out the share buyback programme on its behalf, for a total amount of €500 million (accounting for circa 3.1% of Amundi’s share capital at current price levels). The buyback programme will start on 4 February 2026 and end no later t ...
Amundi launches a 500 million euros share buyback programme
Globenewswire· 2026-02-04 05:59
Core Viewpoint - Amundi has announced a €500 million share buyback program, representing approximately 3.1% of its share capital, aimed at reducing its share capital through the acquisition and cancellation of shares [1][3]. Group 1: Share Buyback Program Details - The buyback program will commence on February 4, 2026, and conclude no later than January 26, 2027 [1]. - Shares will be purchased on the open market and subsequently canceled [1]. - The program has received approval from the European Central Bank and is authorized by the General Meeting held on May 27, 2025 [3]. Group 2: Compliance and Regulatory Framework - The buyback will focus exclusively on Amundi shares traded on Euronext Paris under the ISIN code FR0004125920, adhering to EU regulations [2]. - Any changes to the program's characteristics during execution will be communicated in accordance with French regulatory requirements [3]. Group 3: Current Shareholding and Future Proposals - As of December 31, 2025, Amundi held 1,631,846 of its own shares under a liquidity contract and previous buyback programs, which will not be affected by this new program [4]. - Amundi plans to propose a renewal of the buyback authorization at its next General Meeting, subject to shareholder approval [3]. Group 4: Company Overview - Amundi is the leading European asset manager, managing nearly €2.4 trillion in assets and serving 200 million clients globally [5]. - The company operates with a commitment to responsible investment and has a workforce of 5,600 employees across 34 countries [6].
Analysis: Oil extends gains as escalating US-Iran tensions threaten $15+ surge
Invezz· 2026-02-04 05:58
Oil prices extended gains on Wednesday as tensions between the US and Iran escalated, raising fears of supply disruptions. Renewed tensions have surfaced between the US and Iran following the US down... ...
Pharming Group: Crossing From Speculation To Profitability (NASDAQ:PHAR)
Seeking Alpha· 2026-02-04 05:55
I have a strong inclination towards high-growth companies, often treading in sectors poised for exponential expansion. My expertise lies in understanding and investing in disruptive technologies and forward-thinking enterprises. My approach is a mix of fundamental analysis and future trend prediction. I believe in the power of innovation to yield substantial returns and aim to provide insightful analysis on such companies here on SeekingAlpha.Analyst’s Disclosure: I/we have no stock, option or similar deriv ...
Pharming Group: Crossing From Speculation To Profitability
Seeking Alpha· 2026-02-04 05:55
Core Viewpoint - The focus is on high-growth companies in sectors expected to experience exponential expansion, emphasizing the importance of innovation and disruptive technologies for substantial returns [1]. Group 1: Investment Strategy - The investment approach combines fundamental analysis with predictions of future trends, aiming to identify and invest in forward-thinking enterprises [1]. Group 2: Market Perspective - There is a strong belief in the potential of innovation to drive significant financial returns, highlighting the importance of staying ahead in rapidly evolving industries [1].